-
Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury
May 27, 2020
CAMBRIDGE, Mass., May 27, 2020 /PRNewswire/ -- Kantum Pharma Inc. (Kantum), a biopharmaceutical company focused on developing therapies for the prevention and treatment of damaging inflammation trigge...
Read More -
FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure
May 5, 2020
Bordeaux, May 5, 2020 – FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS),...
Read More -
Acesion Pharma Strengthens Clinical Team with Key Appointments
May 7, 2020
Copenhagen, 5 May 2020. Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, today announced that it has recru...
Read More -
AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
April 28, 2020
April 28, 2020 SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, in...
Read More -
CroíValve announces successful first human use of its Duo Tricuspid Coaptation Valve technology
March 23, 2020
Dublin, Ireland, 23 March 2020 - CroíValve announced today the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The procedure was performed by an expe...
Read More -
Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board
February 24, 2020
Philadelphia, PA, February 24, 2020 – Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing transformative gene therapy-based treatments for cardiovascular disease, tod...
Read More -
Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension
February 6, 2020
February 06, 2020 07:00 AM Eastern Standard Time SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced tha...
Read More -
Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China
November 5, 2019
November 5, 2019 3:30pm Eastern Daylight Time NEW HAVEN, Conn. and NANJING, China, (PRNewswire.com) - Simcere Pharmaceutical Group and Aeromics, Inc. today announce collaboration and exclusive lice...
Read More -
Kantum Pharma Founder to Present Preclinical Data Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury at the American Society of Nephrology Annual Meeting
November 4, 2019
November 4, 2019 3:30pm Eastern Daylight Time CAMBRIDGE, MA (Newswire.com) - Kantum Pharma Inc., a biopharmaceutical company focused on developing therapies for the prevention and treatment of d...
Read More -
CroíValve Secures €4M in Additional Funding to Initiate Clinical Trials
September 12, 2019
September 12, 2019 07:00 AM Eastern Daylight Time DUBLIN (BUSINESS WIRE)– €4 million in additional financing has been secured by CroíValve, a high potential start-up (HPSU) supported by Enterp...
Read More
